Varenicline versus Nicotine Patch with Brief Advice for Smokers with Substance Use Disorders with or without Depression: Effects on Smoking, Substance Use and Depressive Symptoms - Rohsenow - 2017 - Addiction - Wiley Online Library
Varenicline was compared with transdermal nicotine (NRT) for smokers with current substance use disorders (SUD) for effects on 3-month smoking abstinence (primary outcome) and, secondarily, on 3 and 6 month abstinence while adjusting for medication adherence, and on additional smoking and substance use outcomes. Moderation by major depressive disorder history (MDD) and adherence were investigated. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
